-
More often, outpatient surgery staff members find themselves in the unenviable position of telling patients about out-of-pocket responsibilities running into the thousands of dollars.
-
[Editor's note: In this issue of Same-Day Surgery, we put a special focus on compliance with regulated drugs. We've talked with some of the top pharmacy consultants in the country to find out foolproof systems for avoiding diversion and theft. These stories will help you decide where to focus your time and energy, while avoiding liability.]
-
When Robert B. Takla, MD, MBA, FACEP, chief of the Emergency Center at St. John Hospital and Medical Center in Detroit, MI, was named in a lawsuit early in his career, he was certain he hadn't breached the standard of care, though the same may not have been true regarding one of his emergency physician (EP) colleagues.
-
Overcrowding and emergency department (ED) boarding are the two top liability risks that Douglas Brunette, MD, assistant chief of emergency medicine for clinical affairs at Hennepin County Medical Center in Minnesota, sees for EDs currently.
-
When a medical malpractice lawsuit is filed, the emergency physician (EP) and the hospital are often represented by the same defense counsel, but there are times when this is not in the EP's best interest, according to Robert B. Takla, MD, MBA, FACEP, chief of the Emergency Center at St. John Hospital and Medical Center in Detroit, MI.
-
-
If an ED patient dies because she doesn't take antibiotics, as instructed by the emergency physician (EP), this doesn't mean that her family won't later sue for medical malpractice.
-
-
Updates to the darunavir (Prezista®) package insert, specifically sections: 6 Adverse Reactions, 12.4 Microbiology, 14 Clinical Studies and were approved on Oct. 19, 2011, to include results from the 192-week safety, resistance and efficacy data from study TMC114-C211, "A randomized, controlled, open-label Phase 3 trial comparing darunavir/ritonavir 800/100 mg once daily versus lopinavir/ritonavir 800/200 mg per day (given as a twice daily or as a once daily regimen) in antiretroviral treatment-naïve HIV-1-infected adult subjects."
-
Thirty years after the world first became aware of a strange syndrome that caused young men to acquire rare diseases like Pneumocystis carinii pneumonia (PCP) and Kaposi's Sarcoma, nations across the globe continue to battle against the HIV/AIDS epidemic.
